Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Fludarabine +1 More for Sickle Cell Disease
Recruiting1 awardPhase 1
Cleveland, Ohio
This trial is testing a new drug to see if it can help people with sickle cell disease before they have a blood stem cell transplant. The goal is to see if the drug can reduce the patient's cells from rejecting donor cells after the transplant.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.